An executive partner at Flagship Pioneering discusses what’s next for the industry, disruptive technologies, and patient care.
What’s next for the pharmaceuticals industry, amid digital disruption and rapid technological advances? McKinsey’s Martin Dewhurst sat down for a wide-ranging conversation with David Epstein of venture firm Flagship Pioneering to explore ways the sector could shift in coming years.
